Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Filings indexed 1,398 across all filing types
Latest filing 2017-09-14 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Bank of America Merrill Lynch – Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document is a presentation slide deck, indicated by the structure (titles, bullet points, tables summarizing financial data, and explicit mention of a conference: 'Bank of America Merrill Lynch Global Healthcare Conference'). It contains detailed financial performance metrics, segment breakdowns (Fresenius Medical Care, Kabi, Helios), outlooks for 2017, and mid-term targets. This content strongly aligns with an Investor Presentation (IP), which typically accompanies management discussions or earnings releases but is a distinct presentation format used for investor outreach. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR) as it is a presentation summarizing results, not the full statutory filing. It is also not just an Earnings Release (ER) because it is a detailed presentation given at a conference, which usually goes beyond the initial press release highlights. Therefore, Investor Presentation (IP) is the most appropriate classification.
2017-09-14 English
Bank of America Merrill Lynch – European Credit Conference
Investor Presentation Classification · 98% confidence The document is a presentation titled 'Bank of America / Merrill Lynch - European Credit Conference September 13, 2017 – London'. It contains detailed slides covering company overview, business segments (Fresenius Medical Care, Kabi, Helios, Vamed), financial results for H1/2017, and updates on major acquisitions (Akorn and Merck's Biosimilars Business). This structure—a slide deck presenting strategy, segment performance, and recent financial highlights—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief earnings release (ER); it is a comprehensive presentation given to investors/analysts.
2017-09-13 English
Morgan Stanley – 15th Annual Global Healthcare Conference
Investor Presentation Classification · 98% confidence The document is a presentation slide deck, indicated by the structure ('# Title', '## Subtitle', bullet points, tables, and references to specific dates like 'New York, 12 September 2017'). It details financial performance ('Sales 2016', 'EBIT growth', 'Q2/17 Highlights'), market dynamics, and future outlook across various business segments (Fresenius Medical Care, Kabi, Helios). This format, which is used to present strategy and results to investors, strongly aligns with the definition of an Investor Presentation (IP). It is not a full regulatory report (like 10-K or IR), nor is it a short announcement of a report (RPA/RNS).
2017-09-12 English
Roadshow Edinburgh
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow – Edinburgh' and contains extensive slides detailing company performance, market dynamics, growth drivers, and financial outlooks for various business segments (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed). It includes specific financial metrics, segment breakdowns, and forward-looking statements typical of an investor presentation or roadshow material designed to communicate strategy and results to the investment community. The content structure strongly aligns with the definition of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a brief earnings release (ER); it is a detailed presentation.
2017-09-08 English
Goldman Sachs – 14th Annual European Medtech and Healthcare Services Conference
Investor Presentation Classification · 98% confidence The document text is structured as a presentation, indicated by section headers, bullet points, financial tables, and references to specific dates (e.g., 'London, 6-7 September 2017', 'H1/17 Actual', 'Q2/17 Highlights'). It discusses financial performance, market dynamics, growth drivers, and outlook across various business segments (Fresenius Medical Care, Kabi, Helios, Vamed). This format and content strongly suggest an Investor Presentation (IP) given at a conference, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). The document is comprehensive, detailing segment performance and outlook, which aligns with the definition of an Investor Presentation.
2017-09-06 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly contains the header "Directors’ Dealings" and details transactions made by a "person discharging managerial responsibilities" (Dr. Gerd Krick, Member of the administrative or supervisory body). This directly corresponds to the definition of Director's Dealing reports, which are classified under the code DIRS.
2017-09-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.